The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Broker upgrades and rising earnings estimates highlight stocks like ARW, GOLD, CCRN, AMN and PENN amid geopolitical tensions and tech-sector volatility.
AMN's Q4 2025 benefited from labor disruption revenue. However, ex-disruption revenue still exceeded the guidance midpoint. In my view, this supports my bull case on their core demand, which remained healthy. However, until we see a sustained trend, it's an inherently speculative view. AMN helps its healthcare clients with staffing, physician/leadership placement, and technology/workforce solutions.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
AMN Healthcare Services posts a 70% drop in Q4 EPS but forecasts up to 80% revenue growth in Q1 2026, which drives shares higher in after-hours trading.
AMN Healthcare Services, Inc. (AMN) Q4 2025 Earnings Call Transcript
The headline numbers for AMN Healthcare (AMN) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
AMN Healthcare Services (AMN) came out with quarterly earnings of $0.22 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.75 per share a year ago.
Besides Wall Street's top-and-bottom-line estimates for AMN Healthcare (AMN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
AMN Healthcare Services is rated Strong Buy after management signaled the worst of the contingent labor market correction is over. AMN trades at a deeply discounted valuation (~0.3x sales, 3.5x FCF), with management guiding for margin expansion in 2026 and 6% revenue growth from 2027 onward. Taking management's recent revenue guidance and applying a normal net margin of 6% suggests $4+ a share in earnings is possible over the next few years.
AMN Healthcare (AMN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
The headline numbers for AMN Healthcare (AMN) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.